| Net Cash Provided by (Used in) Operating Activities |
$41,833 |
USD |
-32% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$500 |
USD |
-102% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
18,327,364 |
shares |
56% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$36,322 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$532,947 |
USD |
6.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$532,947 |
USD |
6.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$519,530 |
USD |
6.9% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$2,653,832 |
USD |
42% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
$2,615 |
USD |
48% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |